… efficacy and safety of favipiravir for treatment of mild to moderate coronavirus disease (COVID-19…
out- and hospitalized patients with mild to moderate COVID-19 was conducted. Eligible …

… for mild-to-moderate COVID-19 disease [9]. In … mild COVID-19 and another in moderate
COVID-19 patients, were conducted in India. The results of the phase 3 study in mild COVID-19 …

… Our study was designed to be an empirical exploration intended to recruit 125 adult patients
hospitalized with mild/moderate COVID-19; however, only 86 patients were involved in this …

… Authorization in three countries for the treatment of mild COVID-19. The aim of this systematic
review was to find out the safety and efficacy of Molnupiravir in SARS-COV-2 infections. …

… efficacy and safety of oral favipiravir monotherapy in addition to standard supportive care
as compared to standard supportive care alone in patients with mild-to-moderate COVID-19. …

… mild/moderate COVID-19. Findings This study successfully enrolled 86 patients with mild/moderate
COVID-19 … patients hospitalized with mild/moderate COVID-19 over supportive care. …

… patients with COVID-19. This study aimed to establish the efficacy of ivermectin to treat
patients with COVID-19 presenting mild to moderate symptoms, compared with usual care alone. …

… promising efficacy and safety of the APE-treatment regimen in adults with mild COVID-19. …
These findings of this study on serum CRP levels in mild COVID-19 patients agree with the …

… efficacy, clinical efficacy, and safety of nelfinavir in patients with asymptomatic and mild
COVID-19… Asymptomatic and mild COVID-19 patients will be enrolled in 10 university and …

… As the risk of severe COVID-19 increases with age [32], the safety and efficacy of
ensitrelvir in a wide range of patients with COVID-19 will be further assessed in the phase 3, …